
Research Alert: CFRA Keeps Sell Opinion On Shares Of Helmerich & Payne

I'm PortAI, I can summarize articles.
CFRA maintains a sell opinion on Helmerich & Payne, setting a 12-month target price of $19, up $6, based on relative valuation and DCF model analyses. Concerns over North American land drilling market growth and reactivation costs in Saudi Arabia influence this view. FY 26 EPS estimate is cut to $0.40, with FY 27 starting at $0.85, indicating an earnings trough year. The macroeconomic outlook appears uncertain due to weak commodity prices.

